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Abstract Rat aortic vascular smooth muscle cells (VSMCs) 
expressing the MyoD gene formed myotubes at a low frequency 
in the presence of serum but at a high frequency in the absence 
of serum. Expression of an antisense Id gene increased myotube 
formation in the presence of serum indicating that a reduction in 
Id levels is a major mechanism by which serum withdrawal pro- 
motes myotube formation. The role of Id in the development of 
VSMCs was investigated by expressing an antisense Id gene in 
neonatal VSMCs. No evidence was found for the conversion of 
neonatal VSMCs to adult VSMCs in the presence of the anti- 
sense Id gene. Similarly reduction in Id by serum withdrawal also 
failed to cause conversion of the neonatal VSMCs to the adult 
phenotype. These data suggest hat the maturation of neonatal 
smooth muscle cells is not controlled by a VSMC homologue of 
the skeletal muscle basic-helix-loop-helix proteins. 
Key words: Maturation: Vascular smooth muscle cell; Id; 
MyoD; Differentiation 
1. Introduction 
The process of skeletal muscle myogenesis i  relatively well 
understood [1]. Skeletal muscle myogenesis is controlled by at 
least 4 well-characterised proteins including MyoD [2], myo- 
genin [3,4], Myf 5 [5] and MRF 4/herculin/Myf 6 [6]. These 
proteins are transcription factors of the basic helix-loop-helix 
(bHLH) family which act on the enhancer sequences ofskeletal 
muscle specific genes [7]. MyoD, the first discovered and most 
studied of these proteins, binds to its recognition sequence 
either as a homodimer or as a heterodimer with the products 
of the E2A gene [8]. However, only the heterodimer fficiently 
activates transcription of muscle specific genes (e.g. muscle 
creatine kinase). The formation of dimers between MyoD and 
E2A gene products is antagonised bythe protein Id [9], an HLH 
protein with no DNA binding domain. Id can dimerise with 
either MyoD or E2A gene products but since Id has a higher 
affinity for the products of the E2A gene it preferentially forms 
dimers with these proteins. Id/E2A heterodimers are unable to 
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bind to DNA and hence the presence of Id prevents E2A bind- 
ing to MyoD and activating muscle specific enhancers. Since 
Id is expressed at high levels in proliferating, undifferentiated 
myoblasts in the presence of serum and at low levels in non- 
proliferating, differentiated cells it is thought to inhibit differen- 
tiation whilst the cells are proliferating [9,10]. 
In contrast to skeletal muscle there is relatively little informa- 
tion on the process of smooth muscle myogenesis. We have 
previously investigated the relationship between Id expression 
and the differentiation of VSMCs marked by the levels of 
smooth muscle specific myosin heavy chain (SM-MHC) in rat 
aortic vascular smooth muscle cells (VSMCs) [11]. No correla- 
tion was found between Id expression and smooth muscle spe- 
cific protein levels suggesting that Id does not regulate this 
differentiation process. However, this does not rule out a role 
for transcription factors regulated by Id at other points in the 
development of smooth muscle cells. 
Cell culture studies have shown that VSMCs grown from 
neonatal rats and adult rats differ in their morphology and 
growth characteristics [12,13]. VSMCs cultured from aortae of 
neonatal rats have a cobblestone morphology and grow to 
monolayer confluence. These cells are also able to grow in 
platelet poor plasma suggesting that they produce an autocrine 
growth factor [13]. In contrast o neonatal rat VSMCs, cells 
cultured from the aortae of adult rats typically have a spindle 
morphology and grow to a 'hills and valleys' pattern at conflu- 
ence. VSMCs derived from adult rats do not proliferate in 
platelet poor plasma suggesting that they do not produce any 
autocrine growth factor. As the animals age the VSMC pheno- 
type appears to convert from the neonatal to the adult pheno- 
type. We have developed in an in vitro model of the conversion 
of neonatal to adult VSMCs in which neonatal cells are treated 
with HMBA. To determine whether a smooth muscle-specific 
bHLH transcription factor could be regulating this process we 
have investigated the role of Id in this interconversion. 
2. Materials and methods 
2.1. Plasmids 
To generate he sense and antisense Idconstructs he Id gene was cut 
out of the vector pMH18AR [9] with EeoRI and BamHI and the 0.9 kb 
fragment was purified. The overhanging ends of the purified fragment 
were filled in using the Klenow enzyme before the fragment was ligated 
into Sinai cut pMSG (Pharmacia). Vectors carrying Id gene inserts 
were identified by restriction digestion. The orientation of the inserts 
was determined byrestriction mapping and confirmed by cloning XhoII 
XbaI fragments ofthe pMSG-Id vectors into Bluescript KS + followed 
by double stranded sequencing using a Sequenase kit. The vector con- 
struct is shown in Fig. 1. All reactions were carried out as described in
[14]. Plasmid DNA for transfections was prepared by PEG precipita- 
tion as described in [14]. 
All rights reserved. 
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Fig. 1. Plasmid map for the pMSG Id constructs. 
2.2. Cell culture and transfections 
VSMCs from adult rat aortae, derived as described in [15] were 
maintained inDMEM supplemented with 10% FCS. Every 4 days cells 
were released by trypsin/EDTA, diluted 3-fold and plated in new flasks, 
A clone of neonatal VSMCs was derived from 12-day-old rats by a 
modification of the enzyme dispersal method previously described [15]. 
Briefly, cells dispersed from 12-day-old rat aortae were diluted to 
4 x 102. m1-1 in M199 + 10% FCS and plated into 96-well microplates 
at 40 cells'well -~. Arfter 28 days in culture, the cells in wells which 
contained a single colony were released with 25 HI of trypsin/EDTA 
at 37°C and replated into a fresh 96-well microplate containing 200 HI 
of M199 + 10% FCS. When the cells had reached confluence they were 
subcultured into two wells of a 96-well microplate by the same proce- 
dure. Cell populations were expanded by sub-culturing into progres- 
sively larger wells and finally maintained in 75 cm 2 flasks in 
DMEM + 10% FCS. Clones were karyotyped as described previously 
[161. 
Both adult and neonatal VSMCs were infected as described in [17] 
with a MyoD cDNA containing retrovirus, MDSN, derived from LNL- 
6. Briefly, VSMCs were plated in 60 mm petri dishes at a density of 
3 × 10 4. cm :. After 24 h the medium was replaced with 
DMEM + 4/ l l .m l  -~ polybrene and 100 HI viral stock (107 neomycin 
resistant cfu.ml-~). The medium was changed after 16 h to 
DMEM + 10% FCS supplemented with 50 ~tg-ml -~ geneticin. Cells 
were selected for 2 weeks prior to sense or antisense Id transfection a d 
analysis for myotube formation. 
Cells were transfected by electroporation as described in [18] using 
40/.tg of plasmid DNA. After electroporation the cells were allowed to 
recover for 10 min before 9.2 ml ofDMEM + 10% FCS was added and 
the cells were seeded into 12-well plates at 0.5 ml'well -~. Using this 
procedure approximately 10% of the surviving VSMCs express fl-galac- 
tosidase 24 h after transfection with the fl-galactosidase expression 
vector pSVflgal (Promega). 
24 h after electroporation, dexamethasone (1 ~tM) was added to 
initiate transcription ofthe sense and antisense ld genes. The cells were 
then either left lbr a further 72 h in the presence of 10% FCS 
and dexamethasone (1 /tM), or the medium was changed after 24 h 
in the presence of serum and dexamethasone, to serum-free 
DMEM + dexamethasone (1/IM) and the cells were left serum free for 
an additional 48 h. The cells were then either fixed and stained for 
skeletal muscle myosin heavy chain (SK-MHC) or harvested and sub- 
cultured 1: 10, 1:20 and 1:50 into DMEM + 10% FCS. After 2 days 
of culture at low cell density the cells were fixed and stained for SM- 
MHC. Control experiments were similar except that he dexamethasone 
was omitted. 
2.3. Immunocytochemistry andNorthern analysis 
Cells for immunocytochemistry were washed three times in PBS 
(NaC1 137 mM, KC1 2.7 mM, Na2HPO4 8 mM, KHaPO4 1.5 raM) and 
fixed in 70% ethanol and 1% acetic acid for 2 min at room temperature. 
The cells were rehydrated in PBS and washed three times for 3 rain each 
wash. SM-MHC was detected by immunoperoxidase staining carried 
out as described by [15] using a polyclonal antiserum raised against 
chicken gizzard myosin [19] an anti-rabbit FAB fragment raised in goat 
(ICN Flow) and an anti-goat IgG conjugated to peroxidase. 
SK-MHC was stained using a mouse anti-chicken SK-MHC anti- 
body MF20 [20]. After fixing and washing the cells were incubated in 
PBS + 3% BSA for 15 rain then in MF20 diluted 1:5 in PBS + 3% BSA 
at 4°C for 2 h. The cells were washed three times with PBS for 3 min 
each wash and incubated with an anti-mouse IgG antibody conjugated 
to peroxidase for 1 h at room temperature prior to washing with PBS 
and DAB staining. Nuclei in cells staining positive for SK-MHC and 
containing at least 3 nuclei were counted as being myotube nuclei. 
Fig. 2. Skeletal muscle myosin expression and myotube formation in MyoD expressing VSMCs. Cells were infected as described in section 2 and 
plated into 60 mm dishes in the presence of 10% FCS. After 72 h the cells were fixed and stained for skeletal muscle MHC. 
PR. Kemp et al./FEBS Letters 368 (1995) 81-86 83 
Northern analysis was carried out as described in [11] using an Id 
cDNA probe. The Northern blot was autoradiographed on Fuji-RX 
X-ray film for 6 days at -70°C. 
3. Results and discussion 
3.1. Effect of Id on myotube Jbrmation in MyoD transfected 
VSMCs 
Adult vascular smooth muscle cells were infected with a 
retrovirus containing the MyoD gene (MDSN). After selection 
in geneticin (50 pg. ml -l) for 2 weeks the cells (termed VSMC/ 
MDSN) were passaged in the presence of 10% FCS and then 
incubated for 3 days before fixing and staining for SK-MHC. 
Under these conditions 4.5 + 1.5% of the cells converted to 
myotubes (Figs. 2 and 3). When VSMC/MDSNs were plated 
in the presence of 10% FCS for 1 day then serum starved for 
2 days prior to fixing and staining for SK-MHC,  the proportion 
of cells forming myotubes had increased to 51.2 + 5.6%. These 
experiments showed that under conditions where the amount 
of Id mRNA is reduced by serum starvation [11] there is an 
increase in the formation of myotubes. This is consistent with 
the work of [9] on the differentiation of myoblasts. 
To test whether this effect was specifically due to lower Id 
mRNA levels or to serum withdrawal, further experiments were 
carried out in which the cells were transfected with a vector 
containing the Id gene in either the antisense (IDA) or sense 
(IdS) orientation under the control of the dexamethasone in- 
ducible MMTV promoter (as described in section 2). When 
cells transfected with IdA were maintained in 10% FCS for 3 
days, 4.3 + 1.1% of the cells formed myotubes. I f  dexam- 
ethasone (1 pM) was added to the cells 24 h after transfection 
the percentage of cells fusing into myotubes 2 days later in- 
creased to 9.7 + 2.7%, P < 0.05, n = 4 (Fig. 4a). Under similar 
conditions addition of dexamethasone to ldS transfected 
VSMC/MDSNs reduced myotube formation (4.0 +_ 1.1% to 
1.2 + 0.7%, P < 0.05, n -- 4). A similar reduction in myotube 
formation was seen in cells electroporated in the absence of 
plasmid DNA (4.5 + 1.5% to 1.1 + 0.6%, P < 0.05, n = 4) (Fig. 
4a). This means that the effective increase in myotube forma- 
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Fig. 3. Myotube formation of MyoD expressing VSMCs (VSMC/ 
MDSNs) in the presence and absence of serum, Cells were plated into 
12-well plates and grown for 72 h in the presence of 10% FCS, or plated 
into 12-well plates and grown for 24 h then serum starved for a further 
48 h, before being fixed and stained for skeletal muscle myosin. A 
myotube was taken to be a cell staining positive for skeletal muscle 
MHC and incorporating at least 3 nuclei. The number of nuclei in 
myotubes is expressed as a percentage of total nuclei. Data are 
mean + S.E.M. of n = 4 counts, 
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Fig. 4. Myotube formation of VSMC/MDSNs in response to antisense 
Id expression. Cells were electroporated with in the absence of plasmid 
DNA (NO ID), in the presence of 40 pg of IdA or the presence of 40 
/~g IdS. (a) After 24 h in the presence of 10% FCS dexamethasone (1 
pM) was added and the cells were fixed 72 h later. (b) After 24 h in the 
presence of 10% FCS dexamethasone (1/IM) was added. 24 h later the 
cells were put into serum-free DMEM for 48 h before they were fixed 
and stained for skeletal muscle MHC. Data are expressed as percentage 
of total nuclei n myotubes derived as in Fig. 3 (mean _+ S.E.M. ofn = 4 
counts). 
tion due to the IdA vector is 8.6% (from 1.1 + 0.6% for cells 
electroporated in the absence of plasmid DNA in 10% FCS and 
1 HM dexamethasone to 9.7 _+ 2.7% (P < 0.01) for IdA trans- 
fected cells in 10% FCS and 1/IM dexamethasone). The trans- 
fection efficiency under these conditions has been found to be 
approximately 10% of the surviving cells (section 2). Therefore 
the increase in frequency of myotube formation suggests that 
most of the transfected cells expressing antisense Id convert 
into myotubes. 
Serum withdrawal increased myotube formation in VSMC/ 
MDSNs transfected with the IdS vector and in cells electropo- 
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Fig. 5. lnterconversion of VSMCs. (a) Confluent neonatal cells (upper panels) and adult cells (lower panels) were released with trypsin/EDTA, 
resuspended in DMEM + 10% FCS and plated into 96-well plates at normal (1:3, left hand panels) and low (1:20, right hand panels) cell density. 
The cells were grown for 48 h in DMEM + 10% FCS, fixed and stained for SM-MHC content (as described in section 2). (b) Neonatal cells were 
subcultured (1:3) in DMEM + 10% FCS and grown in 96-well plates. Cells in one well were then fixed and stained for SM-MHC (bottom left panel). 
Cells in another well were photographed under phase contrast (top left panel). The medium in the remaining wells was changed to DMEM + 10% 
FCS + 10 mM HMBA and the cells were incubated for a further 48 h. Cells in one well were then fixed and stained for SM-MHC (bottom middle 
panel). Cells in another well were photographed under phase contrast (top middle panel). The medium in the remaining wells was changed to 
DMEM + 10% FCS and the cells were grown to confluence. The resultant cells were subcultured and diluted 1:20 in DMEM + 10% FCS and grown 
for 48 h. Cells in one well were then fixed and stained for SM-MHC (bottom right panel). Cells in another well were photographed under phase contrast 
(top right panel). The micrographs show that neonatal cells can be converted into an adult cell phenotype and both adult and treated neonatal cells 
convert o a large cell phenotype when plated at low cell density. 
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large amounts of SM-MHC (Fig. 5). The converted cells plated 
at this low density also changed into a large non-proliferative 
phenotype which stained strongly for SM-MHC protein (Fig. 
5). Taken together these observations indicate that the cells had 
matured into the adult VSMC phenotype. The formation of 
large non-proliferative VSMCs which stain strongly for SM- 
MHC can also be used as a single cell assay for maturation. 
Both HMBA and similar compounds have been shown to in- 
duce differentiation of other cell types (e.g. erythroleukemia 
cells). Additionally in erythroleukemic cells a reduction in Id 
gene expression has been shown to occur coincidentally with 
differentiation i duced by such agents [9]. 
Fig. 6. Serum withdrawal reduces Id expression i neonatal cells. RNA 
extracted from neonatal/MDSN cells subcultured 1 : 10 in 
DMEM + 10% FCS incubated for 24 h then put into serum-free me- 
dium for 3 days and washed every day with serum-free DMEM. Lane 
1 = RNA extracted from type C/MDSNs subcultured 1 :10 and grown 
in DMEM + 10% FCS for 4 days; lane 2 = RNA was hybridised to an 
Id cDNA probe, washed as described inKemp et al. (1991) and exposed 
to X-ray film at -70°C. 
rated in the absence of plasmid DNA from 4.0 + 0.6% to 
49.5 + 10.1% and 4.5 + 1.5% to 51.2 + 5.6% respectively (Fig. 
4). Under serum-free conditions, dexamethasone (1 ]tM) re- 
duced myotube formation of both IdS transfected cells and cells 
electroporated in the absence of plasmid DNA (Fig. 4b). Serum 
withdrawal also increased myotube formation of VSMC/ 
MDSNs transfected with the IdA vector (to 51.5 + 6.9%). 
However, the addition of dexamethasone under these condi- 
tions had no effect on myotube formation in these cells (Fig. 
4b). 
Taken together these data suggest that the increased forma- 
tion of myotubes by the VSMC/MDSNs upon serum with- 
drawal is due to the reduction in Id expression. The data are 
in agreement with the findings of [9] who showed that Id pre- 
vented MyoD-dependent expression from the muscle creatine 
kinase promoter and the experiments of [10] which showed that 
ectopic expression of Id inhibited the skeletal muscle differenti- 
ation program of C2C12 myoblasts. The data are also consist- 
ent with the hypothesis that Id is a negative regulator of MyoD 
transactivation f myogenesis and indicate that Id is capable 
of inhibiting the expression of genes dependent on MyoD and 
E2A in VSMCs. Consequently the data suggest that Id could 
act as an inhibitor of putative bHLH transcription factors in- 
volved in smooth muscle myogenesis. 
3.2. Maturation of VSMCs 
We, therefore, investigated whether Id regulates the matura- 
tion step of smooth muscle myogenesis using the IdA and IdS 
expression vectors. As a model of VSMC maturation, eonatal 
cells were incubated for 24 h in the presence of HMBA (10 mM) 
then washed and allowed to grow on to confluence. The normal 
cobblestone morphology, typical of neonatal cells, was con- 
verted to the spindle morphology of adult cells (Fig. 5). One 
property of adult but not neonatal VSMCs is that when plated 
at low cell density (1:20) adult but not neonatal VSMCs con- 
vert into a large non-proliferative phenotype which contains 
3.3. The effect of ld on VSMC maturation 
To test the hypothesis that a reduction in Id expression pro- 
motes maturation neonatal cells were transfected with the IdA 
or IdS vectors. The cells were maintained in DMEM + 10% 
FCS for 24 h after transfection then dexamethasone (1/IM) was 
added and the cells were grown for 3 days before being subcul- 
tured to low density (1 : 10, 1:20 and 1:50) incubated for 2 days 
in DMEM + 10% FCS then fixed and stained for SM-MHC. 
Amounts of SM-MHC protein did not increase in any of the 
cells in the presence of the IdA or IdS vectors. Cells electropo- 
rated in the absence of plasmid DNA also failed to increase 
their SM-MHC content. None of the cells underwent the mor- 
phological change to the large smooth muscle cell phenotype. 
This indicates that antisense Id expression did not cause the 
maturation of the neonatal VSMCs to adult VSMCs. One pos- 
sible explanation for these observations would be very high Id 
expression in the neonatal cells. To reduce the level of Id 
mRNA in the neonatal cells they were withdrawn form the cell 
cycle by a process of repeated washing with serum free medium 
and then examined for conversion to adult cells. Neonatal cells 
were plated at low density (1 : 10) and 24 h later the cells were 
washed three times with serum-free medium and then incubated 
in serum free medium. Every 24 h for 3 days these cells were 
washed three times with serum free medium then incubated in 
serum free medium. On the fourth day in serum free medium 
the cells were either harvested by trypsinisation for Northern 
analysis of their Id mRNA content or subcultured at low den- 
sity (1:10, 1:20 or 1:50) into DMEM + 10% FCS. After a 
further 48 h in culture the cells were fixed and stained for 
SM-MHC. Id mRNA levels were significantly reduced by this 
protocol (Fig. 6) however, the neonatal cells did not increase 
their SM-MHC content or change morphology to the large 
VSMC phenotype indicating that they did no! convert into 
adult cells. 
These data suggest that Id is not involved in the conversion 
of neonatal VSMCs to adult type VSMCs and that the conver- 
sion of neonatal to adult VSMCs by HMBA is not regulated 
by Id. The data also agree with a previous tudy which showed 
that transcription factors which regulate SM-MHC gene ex- 
pression [11] are not regulated by Id since an increase in SM- 
MHC gene expression was not observed in VSMCs expressing 
antisense Id. In conclusion the data demonstrate hat Id can 
function as a dominant negative regulator of MyoD in the 
presence of serum in an MyoD transfected adult VSMCs. How- 
ever, the process of VSMC maturation was not regulated by the 
interaction of a smooth muscle specific bHLH transcription 
factor with a product of the E2A gene or any other bHLH 
factor which interacts with Id. 
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